The U.S. Restricted Access Barrier System market size was valued at US$ 190.8 million in 2021 and is expected to hit US$ 329.4 million by 2030, growing at a compound annual growth rate (CAGR) of 6.12% from 2022 to 2030.
Key Takeaways:
· The pharmaceutical application segment accounted for the largest share of 65.0% in 2021 owing to the growing pharmaceutical industry in the U.S., coupled with advantages such as a faster changeover process and easy handling
· The medical application segment is expected to expand at a CAGR of 4.2% from 2021 to 2030. This is attributed to the growing penetration of RABS in this segment owing to its ability to provide septic safety in the critical zone and flexibility for interventions
· The U.S. government is aiming to reduce the reliance on drugs manufactured outside the U.S. by encouraging pharmaceutical companies to set up manufacturing facilities in the U.S., in turn, augmenting the demand for RABS
· In February 2021, Comecer spA partnered with Illuminate Manufacturing Intelligence, a division of ATS (ATA.TO), to develop a production solution integrating its containment equipment portfolio in line with Industry 4.0
Growth Factors:
Increasing demand for modular containment systems, growing biotechnological industry, and rising investments in R&D in the field of biotechnology are expected to drive the market in the U.S. The chemical industry in the U.S. is regaining its lost momentum after the disruptions of the supply chain, plummeting demand, and the negative effects of the COVID-19 pandemic. The demand for a restricted access barrier system (RABS) is likely to witness growth on account of the improving consumer demand, growing shale and natural gas sector, and stabilizing global exports.
The pandemic has led the U.S. government to promote local manufacturing of pharmaceuticals, especially active pharmaceutical ingredients (APIs), which require RABS during manufacturing. This has resulted in augmenting the demand for aseptic manufacturing facilities complementing the market growth in the U.S.
The demand for RABS is expected to witness growth in medical applications owing to its ability to provide septic safety in the critical zone and flexibility for interventions. In addition, efficiency and low capital investment compared to cleanrooms and isolators are anticipated to propel the demand for RABS in the near future.
The chemical industry extensively utilizes RABS for developing new chemicals and manufacturing fine chemicals. RABS is used to prevent the contamination of chemicals, which may hamper the reaction during the manufacture of chemicals and protect the workers that are handling toxic and hazardous chemicals. The growing demand for RABS from the chemical industry is expected to create upswings for the market growth over the forecast period.
RABS are usually cleaned manually followed by a CIP (Clean in Place) unit to clean up commodities. This process is simpler than the cleaning process of isolators, which includes bio-decontamination, which, in turn, is expected to boost the demand for RABS in aseptic filling systems over the forecast period.
Report Scope of the U.S. Restricted Access Barrier System Market
Report Coverage |
Details |
Market Size in 2021 |
USD 190.8 million |
Revenue Projection By 2030 |
USD 329.4 million |
Growth Rate |
CAGR of 6.12% from 2022 to 2030 |
Base Year |
2021 |
Historical data |
2017 - 2020 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Application |
Companies Mentioned |
I.M.A. Industria Macchine Automatiche S.P.A.; Germfree Laboratories, Inc.; Extract Technology; AZBIL TELSTAR, S.L.U.; Syntegon Technologies GmbH; Isolation Systems Inc.; Shanghai Tofflon Science and Technology Co., Ltd.; Ortner Reinraumtechnik GmbH; COMECER S.p.A.; SKAN AG |
Application Insights
The pharmaceutical segment led the market and accounted for 65.0% share in 2021. Most pharmacies prefer RABS over isolators as they are faster in the changeover process. RABS air handling is easier as compared to isolators as they use recycled and re-circulated air. The aforementioned factors are expected to boost the market growth in the U.S.
The medical application segment is expected to expand at a CAGR of 4.9% over the forecast period owing to its ability to provide septic safety in the critical zone and flexibility for interventions. In addition, efficiency and low capital investment compared to cleanrooms and isolators are anticipated to propel the demand for RABS over the forecast period.
Maintaining aseptic conditions in the chemical industry is significant in order to avoid contamination of the product. The RABS setup provides dynamic airflow protection and physical barrier. In the U.S., from the beginning of 2021, the production of chemicals has normalized resulting in the rapid growth of the chemical industry, which is beneficial for the RABS market.
A restricted access barrier system is used in the electrical as well as cosmetic and personal care industries. Manufacturers of cosmetics and personal care products in the U.S. are focusing on using high-quality raw materials as well as consumer safety, resulting in boosting the demand for sterile conditions using RABS in the filling and packaging of the products.
Key Companies & Market Share Insights
The competitive environment in the market is driven by innovation in technology used in restricted access barrier systems. Companies operating in the market are investing significantly in R&D to reduce decontamination cycle time and promote better air handling. The growing demand for fill-finish processing across the globe has compelled manufacturers to form alliances with end-users for the application of RABS.
The presence of a few established global market players in the U.S. market, coupled with the rising demand for extensive R&D in the field of barrier technologies, is expected to increase competition among the market players. Increasing collaborations with contract manufacturers are expected to result in a high competitive rivalry in the market over the coming years. Some prominent players in the U.S. restricted access barrier system market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at U.S. for the period of 2017 to 2030
Key Points Covered in U.S. Restricted Access Barrier System Market Study:
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research scope and assumptions
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third Party Perspective
1.3.5 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation and Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Restricted Access Barrier System Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.6 Industry Analysis - Porter’s Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of substitutes
3.6.4 Threat of new entrants
3.6.5 Competitive rivalry
3.7 PESTEL Analysis
3.7.1 Political Landscape
3.7.2 Economic Landscape
3.7.3 Social Landscape
3.7.4 Technological Landscape
3.7.5 Environmental Landscape
3.7.6 Legal Landscape
3.8 Major Deals & Strategic Alliances Analysis
3.9 RABS Product Design Innovators
Chapter 4 U.S. Restricted Access Barrier System Market: Application Estimates & Trend Analysis
4.1 U.S. Restricted Access Barrier System Market: Application Movement Analysis, 2021 & 2030
4.2 Pharmaceutical
4.2.1 Market estimates and forecasts, 2017 - 2030
4.3 Chemical Manufacturing
4.3.1 Market estimates and forecasts, 2017 - 2030
4.4 Medical
4.4.1 Market estimates and forecasts, 2017 - 2030
4.5 Others
4.5.1 Market estimates and forecasts, 2017 - 2030
Chapter 5 Competitive Landscape
5.1 Key Global Players & Recent Developments & Their Impact on The Industry
5.2 Vendor Landscape
5.3 List of End Users
5.4 List of Key Industry Influencers
5.5 Competitive Dashboard Analysis
5.6 Public Companies
5.6.1 Company Market Position Analysis
5.7 Private Companies
5.7.1 List of Key Emerging Companies and Their Geographical Presence
Chapter 6 Company Profiles
6.1 I.M.A. Industria Macchine Automatiche S.P.A.
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.2 Germfree Laboratories, Inc.
6.2.1 Company Overview
6.2.2 Product Benchmarking
6.3 Extract Technology
6.3.1 Company Overview
6.3.2 Product Benchmarking
6.3.3 Strategic Initiatives
6.4 TELSTAR
6.4.1 Company Overview
6.4.2 Product Benchmarking
6.5 Syntegon Technologies GmbH
6.5.1 Company Overview
6.5.2 Product Benchmarking
6.6 Isolation Systems Inc.
6.6.1 Company Overview
6.6.2 Product Benchmarking
6.7 Shanghai Tofflon Science and Technology Co., Ltd.
6.7.1 Company Overview
6.7.2 Product Benchmarking
6.8 Ortner Reinraumtechnik GmbH
6.8.1 Company Overview
6.8.2 Product Benchmarking
6.9 COMECER S.p.A.
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 SKAN AG
6.10.1 Company Overview
6.10.2 Product Benchmarking